User profiles for Derek Shyr

Derek Shyr

Harvard University
Verified email at mail.harvard.edu
Cited by 353

[HTML][HTML] Next generation sequencing in cancer research and clinical application

D Shyr, Q Liu - Biological procedures online, 2013 - Springer
The wide application of next-generation sequencing (NGS), mainly through whole genome,
exome and transcriptome sequencing, provides a high-resolution and global view of the …

[HTML][HTML] Identity-by-descent detection across 487,409 British samples reveals fine scale population structure and ultra-rare variant associations

J Nait Saada, G Kalantzis, D Shyr, F Cooper… - Nature …, 2020 - nature.com
Detection of Identical-By-Descent (IBD) segments provides a fundamental measure of genetic
relatedness and plays a key role in a wide range of analyses. We develop FastSMC, an …

Comprehensive evaluation of context dependence of the prognostic impact of MYCN amplification in neuroblastoma: A report from the International Neuroblastoma …

K Campbell, D Shyr, R Bagatell, M Fischer… - Pediatric blood & …, 2019 - Wiley Online Library
Background MYCN amplification (MYCN‐A) is an established adverse prognostic factor in
neuroblastoma. The extent to which the prognostic impact of MYCN‐A depends on other …

[HTML][HTML] Unraveling attributes of COVID-19 vaccine acceptance and uptake in the US: A large nationwide study

…, EA Hammershaimb, D Cheng, A Shi, D Shyr… - Scientific Reports, 2023 - nature.com
SARS-CoV-2 vaccines are useful tools to combat the Coronavirus Disease 2019 (COVID-19)
pandemic, but vaccine reluctance threatens these vaccines’ effectiveness. To address …

Unraveling attributes of COVID-19 vaccine hesitancy and uptake in the US: A large nationwide study

…, EA Hammershaimb, D Cheng, A Shi, D Shyr… - MedRxiv, 2021 - medrxiv.org
SARS-CoV-2 vaccines are powerful tools to combat the COVID-19 pandemic, but vaccine
hesitancy threatens these vaccines’ effectiveness. To address COVID-19 vaccine hesitancy …

Feasibility of systematic poverty screening in a pediatric oncology referral center

DJ Zheng, D Shyr, C Ma, AC Muriel… - Pediatric blood & …, 2018 - Wiley Online Library
Background Based on the strong link between poverty and child health outcomes, both the
American Academy of Pediatrics (AAP) and national pediatric oncology associations have …

[PDF][PDF] Sample size calculation of RNA-sequencing experiment: a simulation-based approach of TCGA data

D Shyr, CI Li - J Biomet Biostat, 2014 - pdfs.semanticscholar.org
Power and sample size calculation is an essential component of experimental design in
biomedical research. For RNA-sequencing experiments, sample size calculations have been …

Multicenter Phase II Trial of the PARP Inhibitor Olaparib in Recurrent IDH1- and IDH2-mutant Glioma

K Fanucci, MJ Pilat, D Shyr, Y Shyr, S Boerner… - Cancer Research …, 2023 - AACR
Purpose: Isocitrate dehydrogenase (IDH) 1 and IDH2 mutations (IDH1/2mt) are frequent in
glioma. Preclinical studies suggest IDH1/2mts confer “BRCAness” phenotype, a vulnerability …

What constitutes a valid surrogate end point in cancer clinical trials?

Y Shyr, D Shyr - JAMA oncology, 2020 - jamanetwork.com
Historically, novel postneoadjuvant therapies for patients with early breast cancer have
been assessed in multiyear trials. In an effort to address the unmet need of postneoadjuvant …

[HTML][HTML] Decoding biological age from face photographs using deep learning

O Zalay, D Bontempi, DS Bitterman, N Birkbak, D Shyr… - medRxiv, 2023 - ncbi.nlm.nih.gov
Because humans age at different rates, a person’s physical appearance may yield insights
into their biological age and physiological health more reliably than their chronological age. …